Cognyte Software Ltd.
CGNT
$8.01
$0.040.50%
Weiss Ratings | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.52 | |||
Price History | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -11.49% | |||
30-Day Total Return | -12.84% | |||
60-Day Total Return | -2.55% | |||
90-Day Total Return | 21.73% | |||
Year to Date Total Return | -7.18% | |||
1-Year Total Return | 8.98% | |||
2-Year Total Return | 143.47% | |||
3-Year Total Return | -23.86% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -28.33% | |||
52-Week Low % Change | 28.34% | |||
Price | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $11.12 | |||
52-Week Low Price | $6.21 | |||
52-Week Low Price (Date) | Sep 11, 2024 | |||
52-Week High Price (Date) | Feb 06, 2025 | |||
Valuation | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 573.84M | |||
Enterprise Value | 523.78M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.23 | |||
Earnings Per Share Growth | -86.28% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.80 | |||
Price/Book (Q) | 2.86 | |||
Enterprise Value/Revenue (TTM) | 1.67 | |||
Price | $8.01 | |||
Enterprise Value/EBITDA (TTM) | -66.50 | |||
Enterprise Value/EBIT | -28.59 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 70.91M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | -- | |||
Address | -- | |||
Website | www.cognyte.com | |||
Country | Israel | |||
Year Founded | 2020 | |||
Profitability | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -5.84% | |||
Profit Margin | -4.96% | |||
Management Effectiveness | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -2.50% | |||
Return on Equity | -- | |||
Income Statement | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 313.40M | |||
Total Revenue (TTM) | 313.40M | |||
Revenue Per Share | $4.42 | |||
Gross Profit (TTM) | 215.51M | |||
EBITDA (TTM) | -7.88M | |||
EBIT (TTM) | -18.32M | |||
Net Income (TTM) | -15.57M | |||
Net Income Avl. to Common (TTM) | -15.57M | |||
Total Revenue Growth (Q YOY) | 14.24% | |||
Earnings Growth (Q YOY) | 92.79% | |||
EPS Diluted (TTM) | -0.23 | |||
EPS Diluted Growth (Q YOY) | 90.66% | |||
Balance Sheet | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 74.48M | |||
Cash Per Share (Q) | $1.05 | |||
Total Current Assets (Q) | 264.98M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 214.73M | |||
Current Ratio (Q) | 1.391 | |||
Book Value Per Share (Q) | $2.79 | |||
Total Assets (Q) | 472.08M | |||
Total Current Liabilities (Q) | 190.47M | |||
Total Debt (Q) | 33.36M | |||
Total Liabilities (Q) | 257.35M | |||
Total Common Equity (Q) | 197.88M | |||
Cash Flow | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 9.36M | |||
Cash from Financing (TTM) | -2.45M | |||
Net Change in Cash (TTM) | 41.35M | |||
Levered Free Cash Flow (TTM) | -17.41M | |||
Cash from Operations (TTM) | 34.56M | |||